Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Denali Therapeutics (DNLI) Gross Margin: 2018-2023

Historic Gross Margin for Denali Therapeutics (DNLI) over the last 6 years, with Sep 2023 value amounting to 100.00%.

  • Denali Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2023 from the same period last year, while for Sep 2023 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2023, which is negligibly% changed negligibly from last year.
  • Per Denali Therapeutics' latest filing, its Gross Margin stood at 100.00% for Q3 2023, which was down 0.00% from 100.00% recorded in Q2 2023.
  • Denali Therapeutics' 5-year Gross Margin high stood at 100.00% for Q1 2019, and its period low was 100.00% during Q1 2019.
  • In the last 3 years, Denali Therapeutics' Gross Margin had a median value of 100.00% in 2023 and averaged 100.00%.